MIST Therapies for Enlarged Prostate
What You Need to Know Before You Apply
What is the purpose of this trial?
The investigators wish to perform a prospective study at the Men's Health Clinic in Winnipeg, Manitoba to accomplish two goals: 1) Prospectively describe 1 year outcomes for MIST therapies performed at the clinic 2) perform a head to head comparison of Rezum water vapor therapy vs the iTind device in respect to symptom score improvement, uroflow parameters and side effect profile.
Are You a Good Fit for This Trial?
This trial is for men over 18 with benign prostatic hyperplasia (BPH), also known as an enlarged prostate, who are undergoing Rezum or iTind treatments. It's not suitable for those with a high surgical risk (ASA 3+), recent urinary tract infections, minors, or anyone unable to consent.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Rezum or iTind procedure for BPH/LUTS
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Continued monitoring of symptom scores and uroflow parameters
What Are the Treatments Tested in This Trial?
Interventions
- iTind
- Rezum
iTind is already approved in European Union, United States, Brazil for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor